Delivery Order SPE2DB24D2216-SPE2DB25FGPLF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,980.08 to AmerisourceBergen Drug Corp for the supply of Cyanokit 5 gram vials. This contract represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025, and was competitively awarded without set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. Cyanokit is a critical antidote used in emergency...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,947.02 to AmerisourceBergen Drug Corp for the supply of Cyanokit 5 gram vials. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract carries no set-aside designation, and performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Cyanokit 5 gram vials, with a ceiling value of $1,713.51 and an ultimate completion date of August 5, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Cyanokit is a critical antidote used in emergency medical situations for certain types of poisoning,...
- The Defense Logistics Agency awarded a $1,188.97 delivery order to AmerisourceBergen Drug Corp for Cyanokit 5 gram vials. This contract, executed on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price procurement with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Cyanokit is a critical antidote medication used in emergency medical situations, and this procurement...
- The Defense Logistics Agency awarded a $2,757.08 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Cyanokit 5 gram vials. The contract, designated as a firm fixed price delivery order with no set-aside provisions, is set for ultimate completion on August 14, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Cyanokit is a critical pharmaceutical product used in emergency medical treatment, specifically as an...
- The Defense Logistics Agency awarded a $1,321.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cyanokit 5-gram vials, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order was competitively awarded and represents a single transaction under AmerisourceBergen's larger federal pharmaceutical supply contracts. Cyanokit (hydroxocobalamin) is a critical antidote used in emergency medical response for cyanide poisoning, making it essential inventory...
- The Defense Logistics Agency awarded a delivery order valued at $4,014.57 to AmerisourceBergen Drug Corp for Cyanokit 5 gram vials, with a completion date of September 15, 2025. This is a firm fixed-price, non-set-aside contract issued on September 12, 2025, with performance to occur at the awardee's corporate office location in Conshohocken, Pennsylvania. Cyanokit is a critical antidote medication used in emergency medical situations to treat cyanide poisoning, making this procurement essential...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cyanokit 5 gram vials, with a ceiling value of $13,909.74 under a firm fixed-price contract structure. The award was made on August 8, 2025, with an ultimate completion date of August 11, 2025. No set-aside designation was used for this competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $3,544.33 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Cyanokit 5 gram vials, with an ultimate completion date of September 29, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,346.39 to AmerisourceBergen Drug Corp for the supply of Cyanokit 5 gram vials. This is a firm fixed price, competitively awarded contract with an ultimate completion date of November 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The award includes no set-aside designation, allowing the contract to be...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPLFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,303.85 to AmerisourceBergen Drug Corp for Cyanokit 5 gram vials, with an ultimate completion date of August 7, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The product will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Cyanokit is an FDA-approved antidote for cyanide poisoning, representing a critical medical countermeasure for emergency and military healthcare applications. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and established federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and the Defense Health Agency. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill diverse medical supply needs across multiple therapeutic domains for military and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/6/25 |